I use many factors to come up with my numbers. I take in all info and evaluate. Much more here than just my calculation:
1. Focalin 15 and 30mg is a $200M market. IPCI is getting 1% or $2M in annual revenue from those doses. 2. I am figuring Seroquel as a $700M dollar market. I believe the Seroquel deal is much better for IPCI. So I estimate they will obtain 2-2.5% of that entire market in revenue. 2% equates to $14M annually. 2.5% equates $17.5M annually. Thus, $3-4.5M
We also need to factor increased competition coming in later in 2017. My estimate is $3-4M but am thinking the number is closer to $3M. I have seen anywhere from $3-9M per quarter estimated. Those high estimates are way out of whack. I am conservatively estimating $1M per month or $3M per quarter. I do think it may be a little higher than that, but not by much.